Background
Xander H. T. Wehrens was born on February 4, 1975, in Heerlen, Limburg, the Netherlands. He is the son of J. P. Wehrens and Johann Wolfgang de Vrede.
- Photos
- Works
- Photos
- Works
Other Work
- Wehrens is the author of Novel Insights in the Congenital Long QT Syndrome (2002) and Cardiovascular Genetics (2002). He co-edited Ryanodine Receptors: Structure, Function and Dysfunction in Clinical Disease with Andrew R. Marks and has authored numerous scientific publications on cardiac electrophysiology, calcium signaling, and inherited arrhythmias. He has also served as an associate editor of the International Journal of Cardiology.
Xander Wehrens
Edit Profile
Xander H. T. Wehrens is a Dutch physician, cardiovascular scientist, and medical educator. He is a professor at Baylor College of Medicine and Director of the Cardiovascular Research Institute, where his research focuses on the molecular mechanisms of cardiac arrhythmias, heart failure, and inherited cardiovascular diseases.
Education
Wehrens received his Doctor of Medicine degree from Maastricht University in 2001 and completed a Doctor of Philosophy degree at the same institution in 2002. During his studies, he received awards in the National Mathematics Olympiads and later earned a Clinical Research Award from GlaxoSmithKline.
Career
Wehrens served as Chairman of MMSRC in Maastricht from 1996 to 1997. He was a research associate at Maastricht University between 1998 and 1999 before joining Columbia University in New York as a research scientist from 2002 to 2005.
In 2005, he joined Baylor College of Medicine in Houston as Assistant Professor of Molecular Physiology, Biophysics, and Medicine. He subsequently advanced to professor and became Director of the Cardiovascular Research Institute. He also holds appointments in Cardiology, Integrative Physiology, Pediatrics, Neuroscience, and the Center for Space Medicine. Since 2009, he has served as Associate Director of Baylor's Medical Scientist Training Program.
His research has focused on the regulation of intracellular calcium signaling and ryanodine receptor channels in cardiac muscle, contributing to the understanding of inherited arrhythmia syndromes, atrial fibrillation, heart failure, and sudden cardiac death. His laboratory has helped develop small-molecule therapies and gene-editing approaches for inherited cardiac disorders.
Achievements
-
Wehrens received recognition in the National Mathematics Olympiads in 1993 and a Clinical Research Award from GlaxoSmithKline. His translational research on cardiac calcium signaling and inherited arrhythmias has led to the development of experimental therapies targeting ryanodine receptor dysfunction. He was elected to the American Society for Clinical Investigation in 2011 in recognition of his contributions to cardiovascular research.
Works
Other Work
-
Wehrens is the author of Novel Insights in the Congenital Long QT Syndrome (2002) and Cardiovascular Genetics (2002). He co-edited Ryanodine Receptors: Structure, Function and Dysfunction in Clinical Disease with Andrew R. Marks and has authored numerous scientific publications on cardiac electrophysiology, calcium signaling, and inherited arrhythmias. He has also served as an associate editor of the International Journal of Cardiology.
-
Membership
Wehrens has been a member of the American Heart Association and the Biophysical Society. He is a Fellow of the European Society of Cardiology.
